Home526139 • BOM
add
Transgene Biotek Ltd
Previous close
₹4.80
Day range
₹4.66 - ₹4.94
Year range
₹3.22 - ₹10.40
Market cap
363.70M INR
Avg Volume
22.80K
P/E ratio
-
Dividend yield
-
Primary exchange
BOM
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 765.00K | 70.00% |
Operating expense | 6.42M | 103.46% |
Net income | -7.13M | -169.20% |
Net profit margin | -932.16 | -58.35% |
Earnings per share | — | — |
EBITDA | -5.42M | -116.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.84M | 3,593.51% |
Total assets | 1.44B | 1.24% |
Total liabilities | 1.34B | 1.86% |
Total equity | 100.30M | — |
Shares outstanding | 75.77M | — |
Price to book | 3.64 | — |
Return on assets | — | — |
Return on capital | -5.73% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.13M | -169.20% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1990
Website
